Evidence map›Paper›PMID 20102283›Full record

ArticleStem cells and development2010

Modeling the prostate stem cell niche: an evaluation of stem cell survival and expansion in vitro.

Shona H Lang, Elizabeth Anderson, Robert Fordham, Anne T Collins

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Stem cells and development, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. B4 androgen ablation: attacking the prostate cancer stem cell.The Journal of clinical investigation · 2013
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shona H LangYCR Cancer Research Unit, Department of Biology, University of York, Heslington, York, United Kingdom.
Elizabeth Anderson
Robert Fordham
Anne T Collins
Yorkshire Cancer Research · GB

Funding

Medical Research Council G0900871Wellcome Trust GR076612MA
6 · The paper itself

Abstract

The goal of this work was to engineer a clinically relevant in vitro model of human prostate stem cells (PSCs) that could be used to interrogate the mechanisms of stem cell control. We, therefore, compared the growth potential of stem cells in 3D culture (where the conditions would favor a quiescent state) with monolayer culture that has previously been demonstrated to induce PSC division. We found a fundamental difference between cultures of primary, adult PSCs grown as monolayers compared to those grown as spheres. The first supported the expansion and maintenance of PSCs from single cells while the latter did not. In an attempt to determine the mechanisms governing stem cell control, several known stem cell activators (including IFNalpha, FGF2, anti-TGFbeta, and dihydrotestosterone) were studied. However, cell division was not observed. CD133+ cells derived from a prostate cell line did not grow as spheres from single cells but did grow from aggregates. We conclude that PSCs can be expanded and maintained in monolayer culture from single cells, but that PSCs are growth quiescent when grown as spheres. It is likely that the physical arrangement of cells in monolayer provides an injury-type response, which can activate stem cells into cycle.

Indexed as

AC133 AntigenAgedAged, 80 and overAntibodiesAntigens, CDCell Culture TechniquesCell ProliferationCells, CulturedCell SurvivalDihydrotestosteroneFibroblast Growth Factor 2GlycoproteinsHumansInterferon-alphaMaleMiddle AgedAC133 AntigenAntibodiesAntigens, CDDihydrotestosteroneFibroblast Growth Factor 2GlycoproteinsInterferon-alphaPeptidesPROM1 protein, humanTransforming Growth Factor beta

Identifiers

PMID20102283
PMCPMC3158388
OpenAlexW2005240156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.